Overview
Single-family office investing in cutting-edge technologies and businesses.
Deals · 12mo
3
Links
Stage focus
Geographic focus
Sector focus
Investment portfolio
| NAME | DATE | SIZE | |
|---|---|---|---|
TIBEAY Biosciences | Apr 2026Led | $41 MOther Equity | |
Antheia | Jan 2026Led | $24 MSeries C | |
Bactolife | Jan 2026Participated | $35 MSeries B | |
AMSilk | Sep 2025Led | $61 MOther Equity | |
MRM Health | Sep 2025Participated | $64 MSeries B | |
Antheia | Jun 2025Participated | $56 MSeries C | |
HAYA Therapeutics | May 2025Participated | $65 MSeries A | |
Aignostics | Oct 2024Led | $34 MSeries B | |
Isotopen Technologien München | Jun 2024Participated | $204 MOther Equity | |
Bactolife | Aug 2023Led | $33 MSeries A | |
Isotopen Technologien München | Jun 2023Participated | $273 MOther Equity | |
AMSilk | Apr 2023Led | $27 MSeries C | |
TIBEAY Biosciences | Apr 2026Led | $41 MOther Equity | |
Antheia | Jan 2026Led | $24 MSeries C | |
Bactolife | Jan 2026Participated | $35 MSeries B | |
AMSilk | Sep 2025Led | $61 MOther Equity | |
MRM Health | Sep 2025Participated | $64 MSeries B | |
Antheia | Jun 2025Participated | $56 MSeries C | |
HAYA Therapeutics | May 2025Participated | $65 MSeries A | |
Aignostics | Oct 2024Led | $34 MSeries B | |
Isotopen Technologien München | Jun 2024Participated | $204 MOther Equity | |
Bactolife | Aug 2023Led | $33 MSeries A | |
Isotopen Technologien München | Jun 2023Participated | $273 MOther Equity | |
AMSilk | Apr 2023Led | $27 MSeries C |
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Series A | 1 | 2 |
| Series B | 2 | 2 |
| Series C+ | 2 | 3 |
| Other Equity | 2 | 5 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| Jan '20 | 1 |
| Feb '20 | 0 |
| Mar '20 | 0 |
| Apr '20 | 0 |
| May '20 | 0 |
| Jun '20 | 0 |
| Jul '20 | 0 |
| Aug '20 | 0 |
| Sep '20 | 0 |
| Oct '20 | 1 |
| Nov '20 | 0 |
| Dec '20 | 0 |
| Jan '21 | 1 |
| Feb '21 | 0 |
| Mar '21 | 0 |
| Apr '21 | 0 |
| May '21 | 1 |
| Jun '21 | 0 |
| Jul '21 | 0 |
| Aug '21 | 0 |
| Sep '21 | 0 |
| Oct '21 | 0 |
| Nov '21 | 0 |
| Dec '21 | 1 |
| Jan '22 | 0 |
| Feb '22 | 0 |
| Mar '22 | 0 |
| Apr '22 | 0 |
| May '22 | 0 |
| Jun '22 | 0 |
| Jul '22 | 0 |
| Aug '22 | 0 |
| Sep '22 | 1 |
| Oct '22 | 0 |
| Nov '22 | 0 |
| Dec '22 | 0 |
| Jan '23 | 0 |
| Feb '23 | 1 |
| Mar '23 | 0 |
| Apr '23 | 1 |
| May '23 | 0 |
| Jun '23 | 1 |
| Jul '23 | 0 |
| Aug '23 | 1 |
| Sep '23 | 0 |
| Oct '23 | 0 |
| Nov '23 | 0 |
| Dec '23 | 0 |
| Jan '24 | 0 |
| Feb '24 | 0 |
| Mar '24 | 0 |
| Apr '24 | 0 |
| May '24 | 0 |
| Jun '24 | 1 |
| Jul '24 | 0 |
| Aug '24 | 0 |
| Sep '24 | 0 |
| Oct '24 | 1 |
| Nov '24 | 0 |
| Dec '24 | 0 |
| Jan '25 | 0 |
| Feb '25 | 0 |
| Mar '25 | 0 |
| Apr '25 | 0 |
| May '25 | 1 |
| Jun '25 | 1 |
| Jul '25 | 0 |
| Aug '25 | 0 |
| Sep '25 | 2 |
| Oct '25 | 0 |
| Nov '25 | 0 |
| Dec '25 | 0 |
| Jan '26 | 2 |
| Feb '26 | 0 |
| Mar '26 | 0 |
| Apr '26 | 1 |
| May '26 | 0 |
| Jun '26 | 0 |
| Jul '26 | 0 |
| Aug '26 | 0 |
| Sep '26 | 0 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 15 |
| Consumer & Lifestyle | 3 |
| Manufacturing | 2 |
| AI & Machine Learning | 2 |
| Transportation & Logistics | 2 |
| Developer Tools | 2 |
| Networks, Cloud & Communication | 1 |
| Hardware & Robotics | 1 |
| Professional Services | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 1 |
| $5M-$10M | 1 |
| $10M-$25M | 2 |
| $25M-$50M | 7 |
| $50M-$100M | 6 |
| $100M-$250M | 1 |
| $250M-$500M | 1 |
| $500M-$1B | 0 |
| $1B+ | 0 |
Deals By Geography
Top 2 of 2 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| Europe | 17 |
| United States | 2 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| MIG Capital | 5 |
| Novo Holdings | 4 |
| Temasek | 3 |
| BlackRock | 2 |
| Carbyne | 2 |
| Cargill | 2 |
| Decibel | 2 |
| Global Health Investment Corporation | 2 |
| Qatar Investment Authority | 2 |
| 4See Ventures | 1 |
| Ackermans & van Haaren | 1 |
| Alexandria Venture Investments | 1 |
| Alvogen | 1 |
| America's Frontier Fund | 1 |
| Apollo Health Ventures | 1 |
| Aztiq Pharma | 1 |
| Baxter Ventures | 1 |
| BERNINA BioInvest | 1 |
| Bill & Melinda Gates Foundation | 1 |
| Biocodex | 1 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 7 | 37% |
| Participating | 12 | 63% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 5 | 71% |
| Co-led | 2 | 29% |